ScreenerHero
CDNACareDx, Inc.
NAS · US · Healthcare · Diagnostics & Research · caredx.com
28.50USD-2.66%Mkt Cap: 1.47B $P/E: —

CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company provides AlloSure Kidney, a donor-derived cell-free DNA (dd-…

Industry Peers

Diagnostics & Research
Screen all
vs Diagnostics & Research
P/B
Avg
1M Perf
Lower
TMO
Thermo Fisher Scientific Inc.
$186.32BUSDP/E 27.6
DHR
Danaher Corporation
$134.82BUSDP/E 36.8
LONN
Lonza Group AG
$43.51BUSDP/E 42.0
IDXX
IDEXX Laboratories, Inc.
$41.53BUSDP/E 38.7
NTRA
Natera, Inc.
$38.88BUSD
A
Agilent Technologies, Inc.
$37.53BUSDP/E 26.7
WAT
Waters Corporation
$36.82BUSDP/E 47.7
IQV
IQVIA Holdings Inc.
$32.25BUSDP/E 24.0
ILMN
Illumina, Inc.
$26.60BUSDP/E 31.9
MTD
Mettler-Toledo International Inc.
$25.82BUSDP/E 30.0
DGX
Quest Diagnostics Incorporated
$23.46BUSDP/E 23.4
LH
Labcorp Holdings Inc.
$22.96BUSDP/E 24.8
GH
Guardant Health, Inc.
$19.89BUSD
MEDP
Medpace Holdings, Inc.
$15.12BUSDP/E 33.3
ERF
Eurofins Scientific SE
$12.91BUSDP/E 26.9
RVTY
Revvity, Inc.
$12.41BUSDP/E 53.5
CRL
Charles River Laboratories International, Inc.
$10.92BUSD
BIM
bioMérieux S.A.
$8.81BUSDP/E 20.6
TWST
Twist Bioscience Corporation
$6.41BUSD
BLLN
BillionToOne, Inc.
$5.52BUSDP/E 222.2
SHC
Sotera Health Company
$5.06BUSDP/E 43.3
RDNT
RadNet, Inc.
$4.85BUSD
VCYT
Veracyte, Inc.
$4.69BUSDP/E 54.4
DIA
DiaSorin S.p.A.
$3.65BUSDP/E 25.7
ADPT
Adaptive Biotechnologies Corporation
$3.43BUSD
GRAL
GRAIL, Inc.
$2.93BUSD
WGS
GeneDx Holdings Corp.
$2.04BUSD
NEO
NeoGenomics, Inc.
$1.90BUSD
VIMIAN
Vimian Group AB (publ)
$1.48BUSDP/E 37.4
DIA
Diagnostyka S.A.
$1.48BUSDP/E 22.4
PSNL
Personalis, Inc.
$1.40BUSD
OPK
OPKO Health, Inc.
$1.13BUSD
CBAV
Clínica Baviera, S.A.
$1.01BUSDP/E 21.1
CSTL
Castle Biosciences, Inc.
$723.37MUSD
LBIRD
Lumibird SA
$615.20MUSDP/E 40.1
FLGT
Fulgent Genetics, Inc.
$582.78MUSD
MYGN
Myriad Genetics, Inc.
$539.30MUSD
VOX
Voxel S.A.
$297.38MUSDP/E 3.0
EDT
Spectral Medical Inc.
$282.06MUSD
BDSX
Biodesix, Inc.
$233.52MUSD
IMDX
Insight Molecular Diagnostics Inc.
$190.51MUSD
SLV
Selvita S.A.
$147.80MUSD
XGN
Exagen Inc.
$112.34MUSD
ALECR
Eurofins-Cerep SA
$94.30MUSDP/E 18.2
BIOPOR
BioPorto A/S
$77.88MUSD
PANG
Pangaea Oncology, S.A.
$58.94MUSD
PRPO
Precipio, Inc.
$44.26MUSD
ABDX
Abingdon Health Plc
$27.97MUSD
NN6
NanoRepro AG
$27.15MUSD
GDR
genedrive plc
$22.69MUSD
SENZA
SenzaGen AB
$17.60MUSD
IMMNOV
Immunovia AB (publ)
$12.55MUSD
BMX
BioMaxima S.A.
$10.07MUSDP/E 63.2
ALPRE
Predilife S.A.
$9.85MUSD
VRCI
Verici Dx plc
$9.02MUSD
XWEL
XWELL, Inc.
$8.78MUSD
NDRA
ENDRA Life Sciences Inc.
$6.77MUSD
PRM
Proteome Sciences plc
$6.29MUSD
AVCR
Avricore Health Inc.
$5.98MUSD
BIAF
bioAffinity Technologies, Inc.
$5.10MUSD
OBD
Oxford BioDynamics Plc
$4.66MUSD
ISPC
iSpecimen Inc.
$3.81MUSD
JUMP
Leveljump Healthcare Corp.
$3.86MUSDP/E 2.8
TELO
Telo Genomics Corp.
$2.93MUSD
NOTV
Inotiv Inc
$2.79MUSD
PROGEN
Prostatype Genomics AB (publ)
$2.43MUSD
PRPH
ProPhase Labs, Inc.
$1.29MUSD
MBI-H
Many Bright Ideas Technologies Inc.
$314.2KUSDP/E Infinity
TTOO
T2 Biosystems, Inc.
$14.0KUSD
Indicators:|

Key Statistics

Company
Market Cap1.47B $
Enterprise Value1.31B $
Revenue (TTM)412.82M $
Gross Profit256.57M $
Net Income (TTM)-21.35M $
Revenue/Share7.899 USD
Last Price28.50 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees761
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS14167L1035
Valuation
P/E (Trailing)—
P/E (Forward)25.13
PEG—
EV/EBITDA565.47
EV/Revenue3.17
P/S3.57
P/B4.66
EPS (TTM)-0.16
EPS (Forward)1.13
52W Range
10.9694% of range29.57
52W High29.57 USD
52W Low10.96 USD
Profitability
Gross Margin67.55%
Oper. Margin1.53%
EBITDA Margin0.56%
Profit Margin-5.62%
ROE-7.05%
ROA-5.17%
Growth
Revenue Growth39.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF42.03M $
CapEx (TTM)6.59M $
FCF Margin16.99%
FCF Yield4.76%
Net Debt-162.68M $
Net Debt/EBITDA-70.24
Balance Sheet
Debt/Equity0.09
Current Ratio3.40
Quick Ratio2.93
Book Value/Sh6.115 USD
Cash/Share3.623 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.1 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)25.80 USD
Upside (mean)-9.5%
Target Range21.00 USD – 28.00 USD
$21.00-9.5% to mean$28.00
# Analysts5
Ownership
Shares Out.51.66M
Float49.28M
Insiders3.47%
Institutions101.82%
Short Interest
Short Ratio11.2d
Short % Float16.64%
Short % Out.16.33%
Shares Short8.43M
Short (prev mo.)6.51M
Technical
SMA 5022.49 (+26.7%)
SMA 20018.76 (+51.9%)
Beta2.48
S&P 52W Chg20.05%
Avg Vol (30d)781.10K
Avg Vol (10d)1.19M
Technical Indicators
RSI (14)69.6
MACD1.7953
MACD Signal1.3292
MACD Hist.+0.4660
BB Upper29.53 USD
BB Middle24.67 USD
BB Lower19.81 USD
BB Width39.40%
ATR (14)1.353 USD
Vol Ratio (20d)0.70x